The diagnosis of Guillain–Barré syndrome (GBS) relies on evolving clinical features, supported by cerebrospinal fluid (CSF), laboratory investigations, and electrodiagnostic studies. Early investigations may be nondiagnostic and should not delay treatment when progressive neurological deterioration raises clinical suspicion of GBS. Timely treatment is crucial in optimizing maternal and fetal outcomes.
No takes yet. Share an insight, caveat, or question.
Pereira‐Lindley et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: